Devank Pharmaceuticals Private Limited
About Devank Pharmaceuticals Private Limited
Data last updated:
Devank Pharmaceuticals Private Limited is a private limited company based in Gautam Buddh Nagar, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2019PTC112804. Its GSTIN is 09AAHCD0615N2ZH (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Nripendra Bahadur Singh and Pragati Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Pratima Singh W/O Rohit Kumar Ganga Vihar Dadri, Gautam Buddh Nagar, Uttar Pradesh, India – 203207.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.65 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹8,083 (net margin -1.2%) and EBITDA of ₹20,726 (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Devank Pharmaceuticals Private Limited's registered office is in Gautam Buddh Nagar, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Pratima Singh W/O Rohit Kumar Ganga Vihar Dadri, Gautam Buddh Nagar, Uttar Pradesh, India – 203207
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Devank Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Devank Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Devank Pharmaceuticals Private Limited, buy the company report.
Financials of Devank Pharmaceuticals Private Limited
FY 2025 filings availableDevank Pharmaceuticals Private Limited reported revenue of ₹6.65 Lakh (down 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 31% fall in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,726 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8,083 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | -1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Devank Pharmaceuticals Private Limited, buy the company report.
Board of directors of Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nripendra Bahadur Singh | Director | 25 Jan 2019 | 7 Years 8 Months | Current |
| Pragati Singh | Director | 25 Jan 2019 | 7 Years 8 Months | Current |
Peer comparison
Devank Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sabiscon Pharmaceuticals Private Limited | ₹6.66 Lakh (FY 2025) | 2.0% | Surat, Gujarat, India | |||
| Tacaso Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2025) | 202.0% | Salem, Tamil Nadu, India | |||
| Zeltron Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2021) | -78.0% | Ahmedabad, Gujarat, India | |||
| Devank Pharmaceuticals Private Limitedthis company | ₹6.65 Lakh (FY 2024) | -₹8,083 | -1.2% | -31.0% | Gautam Buddh Nagar, Uttar Pradesh, India | |
| Medwave Pharmaceuticals Private Limited | ₹6.64 Lakh (FY 2020) | 36.0% | Delhi, India | |||
| Ratantray Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2025) | 12.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Devank Pharmaceuticals Private Limited, buy the company report.
Legal cases
Devank Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Commercial suit | Filed against the company by Varmed Pharma Pvt Limited | Disposed |
To see the full case history of Devank Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Devank Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Devank Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCD0615N2ZH | Uttar Pradesh | Active | 07 Feb 2020 |
To see the full GST registrations and return filing status of Devank Pharmaceuticals Private Limited, buy the company report.
Recent activity
Devank Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Nripendra Bahadur Singh was appointed as Director on 25 Jan 2019.
Frequently asked questions
Devank Pharmaceuticals is an active private limited company based in Gautam Buddh Nagar, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 January 2019 (7+ years old) and is registered under CIN U24290UP2019PTC112804.
Devank Pharmaceuticals has 2 current directors:
- Nripendra Bahadur Singh - Director
- Pragati Singh - Director
The latest financial statements of Devank Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Devank Pharmaceuticals is 09AAHCD0615N2ZH, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Devank Pharmaceuticals is U24290UP2019PTC112804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devank Pharmaceuticals has 1 court case on record: 1 filed against it.
Devank Pharmaceuticals was incorporated on 25 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Devank Pharmaceuticals by revenue are Sabiscon Pharmaceuticals Private Limited, Tacaso Pharmaceuticals Private Limited, Zeltron Pharmaceuticals Private Limited, Medwave Pharmaceuticals Private Limited, Ratantray Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Nripendra Bahadur Singh was appointed as Director on 25 Jan 2019. Pragati Singh was appointed as Director on 25 Jan 2019.
The registered office of Devank Pharmaceuticals is at CO Pratima Singh WO Rohit Kumar Ganga Vihar Dadri, Gautam Buddh Nagar, Uttar Pradesh, India – 203207.
Devank Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.